The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: Randomized trial

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 3, 2010, Pages 163-170

  Ojetti, Veronica ^a   Gigante, G ^a   Gabrielli, M ^a   Ainora, M E ^a   Mannocci, A ^b   Lauritano, E C ^a   Gasbarrini, G ^a   Gasbarrini, A ^a  

^a Department of Internal Medicine ^*  (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Lactobacillus reuteri; Lactose breath test; Lactose intolerance; Tilactase

Indexed keywords

LACDIGEST; LACTASE; PLACEBO; PROBIOTIC AGENT; REUTERIN; TILACTASE; UNCLASSIFIED DRUG; BETA GALACTOSIDASE; DIAGNOSTIC AGENT; LACTOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYDROGEN BREATH TEST; LACTOBACILLUS REUTERI; LACTOSE INTOLERANCE; MALE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ABDOMINAL PAIN; BREATH ANALYSIS; COMPARATIVE STUDY; DIARRHEA; ENZYMOLOGY; FLATULENCE; HORMONE SUBSTITUTION; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADULT; BETA-GALACTOSIDASE; BREATH TESTS; DIARRHEA; FEMALE; FLATULENCE; HORMONE REPLACEMENT THERAPY; HUMANS; LACTASE; LACTOBACILLUS REUTERI; LACTOSE; LACTOSE INTOLERANCE; MALE; PAIN MEASUREMENT; PROBIOTICS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951635910     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. SWAGERTY DL, WALLING AD, KLEIN RM. Lactose intolerance. Am Fam Physician 2002; 65: 1845-1850.
2. KRETCHMER N. Lactose and lactase - a historical perspective. Gastroenterology 1971; 61: 805-813. 30.
3. JOHNSON JD. The regional and ethnic distribution of lactose malabsorption. Adaptive and genetic hypotheses. In: Paige DM, Bayless TM, eds. Lactose Digestion. Clinical and nNutritional implications. Baltimore: John Hopkins University Press, 1981: pp. 11-22.
4. GUDMAND-HOYER E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 1994; 59: 735S-741S.
5. SOLOMONS NW. Fermentation, fermented foods and lactose intolerance. Eur J Clin Nutr 2002; 56 (Suppl. 4): S50-S55.
6. ZECCA L, MESONERO JE, STUTZ A, POIRÉE JC, GIUDICELLI J, CURSIO R, GLOOR SM, SEMENZA G. Intestinal lactase-phlorizin hydrolase (LPH): the two catalytic sites; the role of the pancreas in pro-LPH maturation. FEBS Lett 1998; 435: 225-228.
7. CAMPBELL AK, WAUD JP, MATTHEWS SB. The molecular basis of lactose intolerance. Sci Prog 2005; 88 (Pt 3): 157-202.
8. GUDMAND-HOYER E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 1994: 59: 735S-741S.
9. SHAW AD, DAVIES GJ. Lactose intolerance: problems in diagnosis and treatment. J Clin Gastroenterol 1999; 28: 208-216.
10. ROSADO JL, SOLOMONS NW. Sensitivity and specificity of the hydrogen breath analysis test for detecting malabsorption of physiological doses of lactose. Clin Chem 1983; 29: 545-548.
11. KOTLER DP, HOLT PR, ROSENSWEIG NS. Modification of the breath hydrogen test increased sensitivity for the detection of carbohydrate malabsorption. Lab Clin Med 1982; 100: 798-805.
12. DI STEFANO M, VENETO G, MALSERVISI S, CECCHETTI L, MINGUZZI L, STROCCHI A, CORAZZA GR. Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 2002; 122: 1793-1799.
13. PEUHKURI K, VAPAATALO H, NEVALA R, KORPELA R. Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms. Aliment Pharmacol Ther 1999; 13: 81-86.
14. SZILAGYI A, TORCHINSKY A, CALACONE A. Possible therapeutic use of loperamide for symptoms of lactose intolerance. Can J Gastroenterol 2000; 14: 581-587.
15. ROSADO JL, SOLOMONS NW, LISKER R, BOURGES H. Enzyme replacement therapy for primary adult lactase deficiency. Gastroenterology 1984; 87: 1072-1082.
16. CORAZZA GR, BENATI G, SORGE M, STROCCHI A, CALZA G, GASBARRINI G. Beta-galactosidase from Aspergillus niger in adult lactose malabsorption: a double-blind crossover study. Aliment Pharmacol Ther 1992; 6: 61-66.
17. MONTALTO M, NUCERA G, SANTORO L, CURIGLIANO V, VASTOLA M, COVINO M, CUOCO L. MANNA R, GASBARRINI A, GASBARRINI G. Effect of exogenous b-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. Eur J Clin Nutr 2005; 59: 489-493.
18. LAMI F, CALLEGARI C, TATALI M, GRAZIANO L, GUIDETTI C, MIGLIOLI M, BARBARA L. Efficacy of addition of exogenous lactase to milk in adult lactase deficiency. Am J Gastroenterol 1988: 83: 1145-1149.
19. ONWULATA CI, RAO DR, VANKINENI P. Relative efficiency of yogurt, sweet acidophilus milk, hydrolyzed-lactose milk, and a commercial lactase tablet in alleviating lactose maldigestion. Am J Clin Nutr 1989; 49: 1233-1237.
20. RASK PEDERSEN E, JENSEN BH, JENSEN HJ, KELDSBO IL, HYLANDER MOLLER E, NORBY RASMUSSEN S. Lactose malabsorption and tolerance of lactose-hydrolyzed milk. A double-blind controlled crossover study. Scand J Gastroenterol 1982; 17: 861-864.
21. SALTZMAN JR, RUSSELL RM, GOLNER B, BARAKAT S, DALLAL GE, GOLDIN BR. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance. Am J Clin Nutr 1999; 69: 140-146.
22. GUARNER F, SCHAAFSMA GJ. Probiotics. Int J Food Microbiol 1998; 39: 237-238.
23. HENTGES DJ, ED. Human Intestinal Flora in Health and Disease. New York: Academic Press, 1983: pp. 3-31.
24. SUAU A, BONNET R, SUTREN M, GODON JJ, GIBSON GR, COLLINS MD, DORÉ J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799-4807.
25. HOVE H, NORGAARD H, MORTENSEN PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr 1999; 53: 339-350.
26. AROLA H, TAMM A. Metabolism of lactose in the human body. Scand J Gastroenterol Suppl 1994; 202: 21-25.
27. WOLF BW, WHEELER KB, ATAYA DG, GARLEB KA. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the Human Immunodeficiency Virus. Food Chem Toxicol 1998;36: 1085-94.
28. ROSENFELDT V, BENFELDT E, DAM NIELSEN S, FLEISCHLER MICHAELSEN K, JEPPESEN DL, VALERIUS NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-395.
29. SHORNIKOVA AV, CASAS IA, ISOLAURI E, MYKKÄNEN H, VESIKARI T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1996; 24: 399-404.
30. SPECK ML, DOBROGOSZ WJ, CASAS I. Lactobacillus reuteri in food supplementation. Food Technol 1993; 47: 90, 92.
31. MOHER D, SCHULZ KF, ALTMAN DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-1194. (Pubitemid 32378696)
32. STROCCHI A, CORAZZA GR, ANANIA C, BENATI G, MALSERVISI S, CHERCHI MV, CERTO M, MALORGIO E, MARANO M, MAZZEO V, GINALDI L, GIORGETTI GM, PIMPO T, SCIARRETTA G, VENTRUCCI M, QUONDAMCARLO C, PELLI MA, PERRI F. Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol 1997; 29: 122-127.
33. VESA TH, MARTEAU P, KORPELA R. Lactose intolerance. J Am Coll Nutr 2000; 19: 165S-175S.
34. MATTHEWS SB, WAUD JP, ROBERTS AG, CAMPBELL AK. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005; 81: 167-173.
35. JACKSON KA, SAVAIANO DA. Lactose maldigestion, calcium intake and osteoporosis in African-, Asian-, and Hispanic-Americans. J Am Coll Nutr 2001; 20: 198S-207S.
36. BIRGE SJ JR, KEUTMANN HT, CUATRECASAS P, WHEDON GD. Osteoporosis, intestinal lactase deficiency and low dietary calcium intake. N Engl J Med 1967; 276: 445-448.
37. SUAREZ FL, SAVAIANO DA, LEVITT MD. Review article: the treatment of lactose intolerance.Aliment Pharmacol Ther 1995; 9: 589-597
38. LIN MY, DIPALMA JA, MARTINI MC, GROSS CJ, HARLANDER SK, SAVAIANO DA. Comparative effects of exogenous lactase (betagalactosidase) preparations on in vivo lactose digestion. Dig Dis Sci 1993; 38: 2022-2027.
39. JOHNSON AO, SEMENYA JG, BUCHOWSKI MS, ENWONWU CO, SCRIMSHAW NS. Adaptation of lactose maldigesters to continued milk intakes. Am J Clin Nutr 1993; 58: 879-881.
40. FLORENT C, FLOURIE B, LEBLOND A. Rautureau Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985; 75: 608-613.
41. LOMER MCE, PARKES GC, SANDERSON JD. Review article: lactose intolerance in clinical practice-myths and realities. Aliment Pharmacol Ther 2008; 27: 93-103.
42. SAAVEDRA JM, PERMAN JA. Current concepts in lactose malabsorption and intolerance. Annu Rev Nutr 1989; 9: 475-502.
43. GUDMAND-HOYER E, SKOVBJERG H. Disaccharide digestion and maldigestion. Scand J Gastroenterol Suppl 1996; 216: 111-121.